Why the study?
Heart valve replacement with mechanical or biological prostheses entails risk of thromboembolism and bleeding complications, prompting an evaluation of complications related to anticoagulation therapy and the probability of risk.
What is the rate of thromboembolic and hemorrhagic complications in patients with prosthetic heart valves receiving vitamin K antagonists?
Comparison
Optimal vs non-optimal INR
Design
Observational cohort study
Authors
Loading...
Complications linked to non-optimal INR call for vigilant management; leaves open optimal strategies for future trials.
What is the rate of thromboembolic and hemorrhagic complications in patients with prosthetic heart valves receiving vitamin K antagonists?
Patients with mechanical heart valves receiving vitamin K antagonists have a high rate of bleeding and thromboembolic complications, which are strongly associated with non-optimal INR control.
Sánchez-Medina et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: